Serum C-reactive protein and risk of lung cancer: A case-control study

Medical Oncology

Volumn 30, Issue 1, 2013, Pages

  Xu, Ming ^a   Zhu, Minglin ^a   Du, Yinggan ^a   Yan, Bibo ^a   Wang, Qian ^a   Wang, Cong ^a   Zhao, Jinping ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

CRP; Inflammatory; Lung cancer; SNPs

Indexed keywords

C REACTIVE PROTEIN; TUMOR MARKER;

ANGIOGENESIS; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CASE CONTROL STUDY; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE LOCUS; GROUPS BY AGE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ADULT; AGED; BLOOD; FEMALE; GENETICS; GENOTYPE; IMMUNOLOGY; INFLAMMATION; LUMINESCENCE; LUNG TUMOR; MALE; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; INFLAMMATION; LUMINESCENT MEASUREMENTS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 84871165483     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0319-4     Document Type: Article

References (19)

1. Ferlay J, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581-92. (Pubitemid 46359643)
2. Dalaveris E, et al. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer. 2009;64(2):219-25.
3. WHO, Cancer. W.H. Organization, 2007.
4. Minna J, Schiller JH, ed. Harrison's principles of internal medicine. 17 ed. 2008. p. 551-62.
5. Hong S, et al. Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer. Yonsei Med J. 2012;53(1):111-7.
6. Trichopoulos D, et al. Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev. 2006;15(2):381-4. (Pubitemid 43348407)
7. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-7. (Pubitemid 36019639)
8. Mantovani A, et al. Cancer-related inflammation. Nature. 2008;454(7203):436-44.
9. Chiang AC, Massague J. Molecular basis of metastasis. N Engl J Med. 2008;359(26):2814-23.
10. Hara M, et al. Postoperative serum C-reactive protein levels in non-small cell lung cancer patients. Ann Thorac Cardiovasc Surg. 2010;16(2):85-90.
11. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448-54. (Pubitemid 29084777)
12. Nikiteas NI, et al. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol. 2005;11(11):1639-43. (Pubitemid 40520804)
13. Miki C, et al. C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci. 2004;49(6):970-6. (Pubitemid 39012280)
14. Gockel I, et al. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol. 2006;12(23):3746-50. (Pubitemid 43950953)
15. Hashimoto K, et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer. 2005;103(9):1856-64. (Pubitemid 40563258)
16. Douglas JB, et al. Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies. Cancer Epidemiol Biomarkers Prev. 2011;20(2):359-69.
17. Chaturvedi AK, et al. C-reactive protein and risk of lung cancer. J Clin Oncol. 2010;28(16):2719-26.
18. Scott HR, et al. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer. 2002;87(3):264-7.
19. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-99.